Navigation Links
On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigan's Drug Product Liability Law
Date:3/4/2009

DETROIT, March 4 /PRNewswire/ -- On March 4, 2009, the United States Supreme Court in the case of Wyeth v. Levine, rejected the drug company's argument that because it was complying with FDA standards it should be immune from suit. Because of this decision, citizens in all states except Michigan can continue to sue drug companies whose products injure the citizens of those states.

During the term of former Governor John Engler, the Republican legislature passed a statute granting immunity to companies (drug companies) whose products are approved by the FDA. That statute which denied Michigan citizens the right to sue for injuries sustained from dangerous drugs was believed by drug companies to set a pattern which would allow the drug companies to deny the citizens in the other 49 states the right to sue.

Using the theory of "Federal Pre-emption" Wyeth told the United States Supreme Court that under the law it could not change its labeling to warn people such as Mrs. Levine that the Wyeth drug Phenergan by the iv - push method had the potential of causing serious injuries and death, including amputation, because the FDA laws did not allow such a change in the warnings. The United States Supreme Court found this to be untrue after analyzing the existing laws.

Two editorials in the leading medical journals, Journal of the American Medical Association and the New England Journal of Medicine, both criticized the attempts of the drug companies to seek immunity and encouraged the United States Supreme Court not to recognize Federal Pre-emption if it meant preventing state court actions against drug companies. The authors of these editorials pointed to the numerous drug products where drug companies hid information about the dangers of drugs that was only uncovered and made available to the medical profession by the filing of state lawsuits which allowed state courts to order drug companies to turn over documents that the drug companies had either hidden from the FDA or mischaracterized to the FDA.

The decision according to Michigan Trial Lawyer, J. Douglas Peters of Charfoos & Christensen, P.C., "This decision may have a sobering impact on the Republicans in the Michigan Senate which should immediately consider reversing Michigan's unique and unfair law to bring Michigan back into line with the law of the other 49 states, as recognized by the United States Supreme Court in its new decision."

According to Peters, "The drug industry had a special friend in Governor Engler, and Governor Engler tried to export his success for the drug companies in Michigan to the national level where he currently works as a lobbyist for various manufacturing interests."

Peters also stated that he " ... hopes the Michigan legislature will act quickly to change Michigan's consumer hostile drug law in light of this new United States Supreme Court decision, to protect the health, safety and welfare of Michigan citizens."

    For more information contact:
    J. Douglas Peters, Esq.
    Charfoos & Christensen, P.C.
    5510 Woodward Avenue
    Detroit, Michigan  48202
    (313) 875-8080


'/>"/>
SOURCE Charfoos & Christensen, P.C.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. National Multiple Sclerosis(MS) Awareness Week is March 15-21
2. AMERIGROUP Corporation to Present at the Barclays Capital Global Healthcare Conference on March 10
3. Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day
4. Cardiogenesis Corporation to Report 2008 Fourth Quarter and Year-End Results on March 31st
5. Air Methods to Report Fourth Quarter and Fiscal Year 2008 Financial Results on Tuesday, March 10, 2009
6. PLC Systems to Host Fourth Quarter Conference Call on March 12, 2009
7. Osteotech Announces Fourth Quarter and Full Year 2008 Earnings Release and Conference Call; Company to Release Financial Results on Wednesday, March 4, 2009 and Host Call on Thursday, March 5, 2009
8. China Nepstar Chain Drugstore to Announce Fourth Quarter and Fiscal 2008 Financial Results on March 16
9. EyeCare America Offers No-Cost Medical Eye Care to Qualified Seniors In Support of National AMD Month - March 2009
10. March Is National Kidney Month
11. Triple-S Management Corporation to Host Inaugural Investor Day on March 5, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... One of two inventors from Glen Burnie, Md., ... painful for her. "This is why the co-inventor and I have designed a new ... then created a prototype of the patent-pending AV-AIR, a device that serves as an ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, ... families throughout the Five Boroughs, is launching a charity drive to raise funds that ... the traditions and spirit of marines and Navy FMF Corpsmen. Working closely with the ...
(Date:12/7/2016)... ... ... Sharon Kleyne, host of the nationally syndicated radio program, The Sharon Kleyne ... declared on her radio program in November 2016 the need to educate people about ... leaders in corporate America, they are trying to take advantage of successful algorithms and ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John ... by donating a portion of proceeds to two local organizations: North Chicago Animal Control ... & Friends is a team of authorized and trained volunteers who support rescued ...
(Date:12/7/2016)... ... December 07, 2016 , ... Texas Premier ... operations" carried out by unethical locksmith companies and is urging Search Engines to ... According to Texas Premier Locksmith, these fraudulent locksmith services take advantage of consumers ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016   AlloSource ... cartilage, cellular, bone, skin and soft-tissue allografts for ... , Business Process Manager, for being named to ... Baldrige National Quality Award by the Commerce Department,s ... the organization,s commitment to process excellence. The Baldrige ...
(Date:12/6/2016)... BOSTON , Dec. 6, 2016  BTL ... evaluation proving that its BTL Vanquish ME device ... homogenous energy delivery to the targeted tissue. The ... reduction, 53% higher, with BTL Vanquish ME versus ... providing our physician network and their patients with ...
(Date:12/6/2016)... opioids commonly used for pain management for workplace injuries, employers now ... to nationwide fatalities. The synthetic opioid called U-47700, or ... morphine, resulting in likelihood of addiction, abuse or death. ... , , ... for HMC HealthWorks, explained the opioid drug is less expensive yet ...
Breaking Medicine Technology: